The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?

We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator’s reach and to a concertation model with assessment and apprais...

Descripción completa

Detalles Bibliográficos
Autor principal: Wilder, Philippe Van
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069942/
https://www.ncbi.nlm.nih.gov/pubmed/33920150
http://dx.doi.org/10.3390/ph14040352
_version_ 1783683355282243584
author Wilder, Philippe Van
author_facet Wilder, Philippe Van
author_sort Wilder, Philippe Van
collection PubMed
description We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator’s reach and to a concertation model with assessment and appraisal being mixed which results in poorly effective policy measures.
format Online
Article
Text
id pubmed-8069942
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80699422021-04-26 The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition? Wilder, Philippe Van Pharmaceuticals (Basel) Commentary We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator’s reach and to a concertation model with assessment and appraisal being mixed which results in poorly effective policy measures. MDPI 2021-04-10 /pmc/articles/PMC8069942/ /pubmed/33920150 http://dx.doi.org/10.3390/ph14040352 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Wilder, Philippe Van
The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
title The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
title_full The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
title_fullStr The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
title_full_unstemmed The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
title_short The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
title_sort off-patent biological market in belgium: is the health system creating a hurdle to fair market competition?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069942/
https://www.ncbi.nlm.nih.gov/pubmed/33920150
http://dx.doi.org/10.3390/ph14040352
work_keys_str_mv AT wilderphilippevan theoffpatentbiologicalmarketinbelgiumisthehealthsystemcreatingahurdletofairmarketcompetition
AT wilderphilippevan offpatentbiologicalmarketinbelgiumisthehealthsystemcreatingahurdletofairmarketcompetition

Ejemplares similares